Back to results
WithdrawnPhase 3

A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disease

NCT05286853

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

IMIM Hospital del Mar Medical Research Institute

Barcelona, Spain

+2 additional locations

View on ClinicalTrials.gov
A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disease — TrialFind